1
2
July 7, 2021 —Researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and ...
Feb. 9, 2022 —Scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease -- even long after treatment with monoclonal ...
Aug. 2, 2021 —Several proteins have been identified in hosts that interact with Ebola virus and primarily function to inhibit the production of viral genetic material in cells and prevent Ebola virus infection, ...
June 25, 2021 —Researchers have discovered a key way that one of the world's deadliest pathogens, Ebola virus, evades the immune system. Understanding this process provides new potential targets for the future ...
Dec. 14, 2022 —Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to new ...
Feb. 11, 2021 —Ebola is so pernicious because it pulls a fast one on the body, disguising itself as a dying cell. A study identifies a pathway that all filoviruses use to gain entry into our cells -- and shows how ...
Apr. 14, 2021 —A new study shows how one of Ebola virus's key proteins, VP40, uses molecular triggers in the human cell to transform itself into different tools for different ...
Apr. 16, 2021 —Some survivors of ebolavirus outbreaks make antibodies that can broadly neutralize these viruses -- and now, scientists have illuminated how these antibodies can disable the viruses so effectively. ...
Feb. 8, 2021 —Researchers have identified a previously unknown site on the filovirus glycoprotein to which small drug molecules can bind and prevent infection -- blocking both sites may be a more effective ...
Jan. 30, 2023 —A new article shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine could someday be an ...